10x Genomics Stock Market Value
| TXG Stock | USD 15.30 0.99 6.92% |
| Symbol | 10X |
10X Genomics Price To Book Ratio
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 10X Genomics. If investors know 10X will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 10X Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.52) | Revenue Per Share 5.261 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) | Return On Equity (0.25) |
The market value of 10X Genomics is measured differently than its book value, which is the value of 10X that is recorded on the company's balance sheet. Investors also form their own opinion of 10X Genomics' value that differs from its market value or its book value, called intrinsic value, which is 10X Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 10X Genomics' market value can be influenced by many factors that don't directly affect 10X Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 10X Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if 10X Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 10X Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
10X Genomics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to 10X Genomics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of 10X Genomics.
| 07/05/2023 |
| 11/26/2024 |
If you would invest 0.00 in 10X Genomics on July 5, 2023 and sell it all today you would earn a total of 0.00 from holding 10X Genomics or generate 0.0% return on investment in 10X Genomics over 510 days. 10X Genomics is related to or competes with Twist Bioscience, Fate Therapeutics, Beam Therapeutics, Veracyte, and Guardant Health. 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for ana... More
10X Genomics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure 10X Genomics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess 10X Genomics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 31.04 | |||
| Value At Risk | (5.62) | |||
| Potential Upside | 4.94 |
10X Genomics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for 10X Genomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as 10X Genomics' standard deviation. In reality, there are many statistical measures that can use 10X Genomics historical prices to predict the future 10X Genomics' volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.73) | |||
| Total Risk Alpha | (1.25) | |||
| Treynor Ratio | (0.36) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 10X Genomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
10X Genomics Backtested Returns
10X Genomics secures Sharpe Ratio (or Efficiency) of -0.1, which signifies that the company had a -0.1% return per unit of risk over the last 3 months. 10X Genomics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm 10X Genomics' mean deviation of 2.99, and Variance of 20.22 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.53, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, 10X Genomics will likely underperform. At this point, 10X Genomics has a negative expected return of -0.47%. Please make sure to confirm 10X Genomics' total risk alpha, as well as the relationship between the skewness and day median price , to decide if 10X Genomics performance from the past will be repeated sooner or later.
Auto-correlation | 0.74 |
Good predictability
10X Genomics has good predictability. Overlapping area represents the amount of predictability between 10X Genomics time series from 5th of July 2023 to 16th of March 2024 and 16th of March 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of 10X Genomics price movement. The serial correlation of 0.74 indicates that around 74.0% of current 10X Genomics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.74 | |
| Spearman Rank Test | 0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 38.59 |
10X Genomics lagged returns against current returns
Autocorrelation, which is 10X Genomics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting 10X Genomics' stock expected returns. We can calculate the autocorrelation of 10X Genomics returns to help us make a trade decision. For example, suppose you find that 10X Genomics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
10X Genomics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If 10X Genomics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if 10X Genomics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in 10X Genomics stock over time.
Current vs Lagged Prices |
| Timeline |
10X Genomics Lagged Returns
When evaluating 10X Genomics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of 10X Genomics stock have on its future price. 10X Genomics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, 10X Genomics autocorrelation shows the relationship between 10X Genomics stock current value and its past values and can show if there is a momentum factor associated with investing in 10X Genomics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether 10X Genomics is a strong investment it is important to analyze 10X Genomics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact 10X Genomics' future performance. For an informed investment choice regarding 10X Stock, refer to the following important reports:Check out 10X Genomics Correlation, 10X Genomics Volatility and 10X Genomics Alpha and Beta module to complement your research on 10X Genomics. For more detail on how to invest in 10X Stock please use our How to Invest in 10X Genomics guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
10X Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.